Curex GLP-1 Reviews (2026): Is It Legit, What It Really Costs, and the Catch

Curex GLP-1 reviews come with a catch: its Trustpilot profile mixes allergy care and weight loss. Curex, a real telehealth company, sells compounded semaglutide and tirzepatide, which are not FDA-approved. Its ads say $49 for month one. Its own price list lists semaglutide at $299 monthly or $2,388 prepaid for a year.

Tirzepatide is $399 a month, or $3,588 up front. The FDA sent Curex a GLP-1 warning letter in 2025, and Curex has posted a 2026 FDA follow-up. Below, we line up the places Curex's own pages disagree, do the math on prepaying, and show what to get in writing before you pay.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

RX Index Decision Verdict: A real company with a low first-month offer, but its own pages disagree on price, refunds, and states, and it has an FDA warning letter plus a follow-up posted by Curex — get your price and refund terms in writing before you pay.

• Best for: Cash-paying adults whose clinician says a compounded medicine meets a need an FDA-approved one can't, who want no membership fee, and who will pay monthly or check the 8-to-10-month break-even point below before prepaying.
• Not ideal for: Anyone who wants an FDA-approved medicine, insurance billing, a refund they can count on, or a needle-free option with clinical trials behind it.
• The factor that matters most: The renewal price and refund terms on your own checkout screen, not the ad.

Already a Curex patient with a charge or cancel question? Skip to cancel and refund help.

The catch: where Curex's own pages disagree

Curex's ads, its price list, its Terms of Use, and its state pages don't give one answer on price, refunds, canceling, or where it operates. We read each of them on October 20, 2026. Here they are side by side, in Curex's own words where the wording matters.

Think of it like a car ad. The big print says "$199 a month." The small print says "$2,388 due today." Both can be true. You just need to know which one you're signing.

One honest limit: no review can tell you what your exact checkout price will be or whether a clinician will prescribe for you. What we can do is line up the public prices, terms, and letters we checked, so you know exactly what to ask. Before you pay, screenshot the checkout screen with the plan name, the amount due today, and the renewal date and amount. If any of it doesn't match the ad, ask Curex in writing first. The questions to send are below.

How much does Curex really cost?

Curex's own price list, dated October 12, 2026, puts compounded semaglutide at $299 a month or $2,388 prepaid for a year, and compounded tirzepatide at $399 a month or $3,588 prepaid. Its ads show first-month sale prices starting at $49. The price list doesn't say whether your price changes with your dose or how many days each payment covers, so ask.

Sources: price list, sale page, main GLP-1 page. Checked October 20, 2026.

Month 1, month 4, and year one

True Monthly Cost is the whole receipt, not the sticker price. Here's what each Curex plan charges at three points, using its list prices. These are base plan charges; labs and other extras below are unknown. The sale examples assume the first-month offer applies and later monthly charges match the price list. Curex's public pages don't confirm that pairing for every offer.

A few more lines belong on the receipt, and their amounts aren't published. That doesn't make them zero:

• Labs and extra medicines. Curex says its clinicians may order these, they aren't covered by the plan, and you may be able to use insurance for them.
• The consultation fee. If you complete a consultation but aren't prescribed, Curex's Terms let it keep up to $100.
• Sale codes. We couldn't confirm a current code in the sale-page text we retrieved on October 20, 2026. If your offer has one, check the total after the code, the plan length, and the renewal price before paying.

Prepay or pay monthly? The 8-to-10-month rule

At Curex's list prices, prepaying semaglutide costs less once you reach month 8. For tirzepatide, it's month 9. If the $49/$149 first-month sale applies and later charges match the list, those points move to 9 and 10 months. Stop sooner, and paying monthly would have cost less, because Curex's Terms say unused prepaid months aren't refunded.

Bold marks the month paying monthly catches up to prepaying. If a first-month sale lowers month 1 to $49 or $149, the catch-up point moves out one more month, to month 9 for semaglutide and month 10 for tirzepatide. A discount that cuts the prepaid price changes this math too, so redo it with the numbers on your checkout screen.

Here's how that plays out. Say you prepay $2,388 for semaglutide in January. By April, the nausea hasn't settled, and your clinician suggests stopping. Paying monthly, you'd have spent $1,196 by then. Prepaid, you've spent $2,388, and the published cancellation terms offer no refund for unused months. Don't count on the separate money-back guarantee without its written conditions.

Many people have a treatment gap in their first year. In a large U.S. study of adults with overweight or obesity, an estimated 53.6% went at least 60 days without a GLP-1 medicine on hand within one year. This was not a study of Curex. Here's what the data says about staying on treatment. If you're not sure you'll reach your plan's break-even month, paying monthly keeps less money at risk.

What's included, and what can cost extra

Curex says the price covers your medical intake review, prescription, medication, and free shipping, plus ongoing support from its care team. It says there's no membership fee.

Curex advertises its GLP-1 plans at self-pay prices. Curex says it accepts HSA and FSA cards. That's four different questions, though: whether insurance covers a drug, whether a savings card applies, whether a checkout takes your HSA or FSA card, and whether the IRS counts it as a qualified expense. Here's how HSA and FSA rules work for compounded GLP-1s.

Why review sites quote different Curex prices

You'll see $49, $149, $179, $199, $299, and $399 on different pages. Promos rotate, and some sites call $199 the ongoing price. On Curex's own list, $199 is what a year of prepaid semaglutide works out to per month, but you pay the whole $2,388 at once.

Check two numbers before anything else: the amount due today and the renewal amount. Our GLP-1 cost calculator and our list of hidden fees to watch for help you compare a real quote.

Curex is one path. Whether it's your best one depends on your state, your insurance and its formulary (the plan's covered-drug list), whether you want FDA-approved or compounded medicine, a shot or a pill, and your budget. The RX Index's Find My GLP-1 Path tool asks a few quick questions, then shows the GLP-1 paths and providers that fit your goals, budget, insurance, and situation. It's free, takes about 2 minutes, and needs no signup.

See which GLP-1 path fits you

What Curex GLP-1 reviews actually say

Curex holds 4.3 out of 5 stars on Trustpilot from 106 reviews, but that profile covers both allergy care and weight loss. It isn't a GLP-1-only rating. The Better Business Bureau (BBB) rates Curex, Inc. a C. Reviews tell you about service and billing, not whether a medicine is safe or works.

The few GLP-1 reviews we found

Here are GLP-1 experiences we checked on Trustpilot and BBB, good and bad:

• A smooth start. Rock Dodge (Trustpilot, 5 stars, September 2026) described monthly provider check-ins, dose adjustments, on-time shipments, and responsive support by text.
• A big result. Victoria Kliewer (Trustpilot, 5 stars, February 2026) said she lost over 50 pounds on tirzepatide. That's one person's report, not a typical result.
• A prepaid year gone wrong. Todd G (BBB, December 8, 2025) said he bought a yearly GLP-1 plan, got hives and swelling after Curex changed the compounded formula, and was told to throw out two shipments. He says Curex later counted those shipments against his yearly supply and closed the account. No business reply was shown under that BBB review. A matching 2-star account appears on Trustpilot, where Curex replied on December 8, 2025 and asked the reviewer to contact support.

Two BBB complaints from GLP-1 patients show the same two risks:

• Cancel timing. A compounded tirzepatide patient (June 2, 2026) said she was charged after canceling. Curex replied that both shipments were delivered and no cancel request was on file before renewal. She disputed that. She also said the patient portal seemed built around allergy care, which made billing and cancel details hard to find.
• The needle-free forms. In a BBB complaint and follow-up, a patient on a sublingual (under-the-tongue) GLP-1 said it didn't work after three months and cost over $400. In its December 22, 2025 reply, Curex said these forms are "generally less potent and slower-acting" than injections, and that its provider had recommended a shot. That is Curex's statement, not a clinical trial comparing the products.

The before-and-after stories in Curex's ads

Curex's sale page shows members who lost 52, 72, even 96 pounds, each tagged "Verified." The fine print says results are based on self-reported data and that individual results may vary. These are stories Curex chose. They aren't typical results, and they don't show that a compounded product works.

Is Curex legit? Who's behind it

Yes, Curex is a real company. Curex, Inc. was incorporated in November 2019 and started as an online allergy clinic; its GLP-1 program came later. Curex runs the website and billing, its affiliated medical groups' clinicians decide whether to prescribe, and outside pharmacies make and ship the medicine.

A few more lines from the Terms worth knowing before you sign:

• Arbitration. Most disputes go to private, one-on-one arbitration in New York instead of court, under Delaware law.
• Liability cap. Curex seeks to limit what it owes you to $100, where the law allows.
• The date. The Terms page says "Last Updated: November 1st, 2021." That date alone doesn't prove nothing has changed since. Save a copy of the version you accept.

Is it the same Curex as the allergy drops? Yes. Same company, same website.

Has the FDA warned Curex?

Yes. On September 9, 2025, the FDA sent Curex a warning letter saying five claims on its website, such as "clinically proven success" and "the same active ingredients as Ozempic or Mounjaro," were false or misleading for compounded drugs. According to letters Curex has posted, the FDA asked for more changes on May 27, 2026, and Curex says it made them by June 22, 2026.

What the letter is, and isn't. It's about marketing claims. It doesn't report a recall, a shutdown, failed batch tests of Curex products, or harm to a patient. The same day, FDA announced a wider crackdown on deceptive drug advertising.

What we saw on October 20, 2026. The text retrieved from three distinct Curex landing pages (1, 2, 3) still included the phrase "clinically proven success." A fourth address redirected to page 3. The first two also said "Clinically proven weight loss treatments," and the first said "Lose up to 20% of your weight," with a footnote mark but no footnote we could find. Those are the kind of claims the FDA flagged.

To be fair to Curex, it publishes its FDA letters and its answers in full, and it says it believes it complies with the FDA and state boards. More companies should be that open. For the bigger picture, see our compounded GLP-1 enforcement tracker.

Which pharmacies make Curex's GLP-1s?

Curex told the FDA in June 2026 that four state-licensed 503A pharmacies compound its GLP-1 products. One of them, Boothwyn Pharmacy, got an FDA warning letter in January 2026 citing weak semaglutide and tirzepatide injections and a tirzepatide product lot that failed sterility testing. Your medicine's label names the pharmacy that made your order.

We looked up each pharmacy in FDA records on October 20, 2026:

No review, including this one, can verify the batch in your box. Your label gives you the pharmacy and lot details to start checking; it doesn't prove the batch's quality:

1. Read the pharmacy name and address on your label.
2. Search that name on FDA's warning letter page and your state board of pharmacy.
3. If the medicine looks different than expected or the label has errors, call the pharmacy on the label before you use it. The FDA lists those as red flags, and it says it has had complaints of compounded GLP-1s arriving warm, so check that too.

More on spotting bad products: how to avoid fake GLP-1 medications online.

Are Curex's GLP-1s FDA-approved? Is compounding still allowed?

No. Curex sells compounded semaglutide and tirzepatide, which the FDA doesn't review for safety, effectiveness, or quality before they're sold, and Curex says plainly it doesn't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro. Compounding is still legal in limited cases, and the FDA says compounded drugs should only be used when an FDA-approved drug can't meet a patient's medical need.

Compounded drugs aren't generic versions of brand-name drugs. Curex says so itself on its GLP-1 page, and that's to its credit.

Here's where the rules stand, from FDA's own pages:

• The shortages are over. On October 20, 2026, FDA's current shortage database did not list semaglutide injection or tirzepatide injection as currently in shortage. FDA's April 2026 policy update also says neither is on the 503B bulks list.
• No regular copies. A 503A pharmacy can't regularly make "essentially copies" of approved drugs. The exception is when a prescriber documents a change that makes a significant difference for a specific patient.
• Adding B12 isn't automatically a difference. FDA says a semaglutide-plus-B12 product may still count as a copy. Curex says its medicines may include vitamin B12. On September 18, 2026, the FDA told Empower, a different compounder, that its semaglutide-with-B12 and tirzepatide-with-niacinamide products appear to be essentially copies (FDA warning letter).
• A separate 503B proposal. On May 1, 2026, the FDA proposed keeping semaglutide, tirzepatide, and liraglutide off the 503B bulks list (Federal Register). The extended comment period closed July 30, 2026. We found no final determination in the official records checked as of October 20, 2026. This proposal concerns 503B outsourcing facilities, a different category from the 503A pharmacies Curex names.
• Supply can change. Any compounded program, Curex included, can lose a product with little notice when rules or enforcement shift. Here's whether compounded GLP-1s are still available.

As of May 31, 2026, the FDA had received 990 adverse event reports tied to compounded semaglutide and more than 730 tied to compounded tirzepatide. FDA says these are likely underreported (FDA). These are reports across compounded products, not Curex-specific counts or a measured risk rate. A report does not establish that the medication caused the event.

A lower price or no insurance, by itself, doesn't meet FDA's patient-specific medical-need standard. If you're weighing compounded medicine, ask your clinician why it fits you better than an FDA-approved option. Our guide to compounded vs. brand-name GLP-1s walks through the trade-offs.

Talk to your own clinician first if this is you

If you're under 18, pregnant or planning a pregnancy, have type 1 diabetes, or have had an eating disorder, start with a clinician who knows your history. Curex's Terms require users to be 18 or older.

The FDA-approved labels for Wegovy (revised June 2026) and Zepbound say not to use them if you or your family have had medullary thyroid carcinoma (MTC, a type of thyroid cancer), or if you have MEN 2, a rare genetic condition. Compounded versions have no FDA-approved label of their own, so ask your clinician and pharmacist about your exact product. See GLP-1 hard contraindications and GLP-1s, pregnancy, and birth control.

Do Curex's dissolving tablets and drops work?

We did not identify a published human trial of Curex's specific compounded tablets or drops. Evidence for approved pills or injections does not show how Curex's forms perform. The FDA hasn't approved a GLP-1 that dissolves under the tongue or comes as drops. Curex's reply to the BBB complainant above is a company statement, not clinical evidence.

The word "tablet" tells you a medicine's shape. It doesn't tell you that two tablets have the same formula, absorb the same way, or have the same proof behind them.

California note: Curex says state rules limit California patients to its tablets, with no shots. That's Curex's statement; we didn't check the state rule.

More options without needles: GLP-1s without needles and the best FDA-approved GLP-1 pill.

If "no needles" is what drew you to Curex, there are now FDA-approved GLP-1 pills for weight loss. Ro lists the Wegovy pill and Foundayo starting at $149 a month for the starting dose. At the Wegovy pill's top price tier ($299), the medicine costs the same as Curex's month-to-month semaglutide, but it's FDA-approved. Ro's membership is a separate charge: $39 the first month, then $149 paid monthly, or $888 prepaid for the next 12 months ($74 a month equivalent) (Ro pricing, checked October 20, 2026). Prescribing isn't guaranteed. Read our Wegovy pill reviews and Foundayo reviews.

Paid link: See Ro's GLP-1 pill prices

Curex vs. the same money spent elsewhere

Curex's listed plan charges are lower than the FDA-approved examples below. For 12 medication purchases, the Wegovy pill through Ro takes $1,428 more cash than Curex's semaglutide on monthly plans, or $1,877 more with the prepayments shown. Ro's prepayment also buys one extra membership month. What the extra money buys is an FDA-approved medicine with its own label and trials.

Prices checked October 20, 2026 on Ro's pricing page, Lilly's full self-pay terms, and Embody's product pages linked below. The assumptions are in the last column so you can redo the math.

These are worked price examples, not a quote for the next year. The Zepbound example holds today's prices fixed and assumes 12 fills in one calendar year: 11 using the current card and the last at the regular price. A new patient cannot lock in that total. The card ends December 31, 2026, and next year's terms are unconfirmed.

One catch on supply length. Twelve Zepbound fills cover 336 days; thirteen cover 364 days. The card allows up to 11 fills per calendar year. Ro's prepaid membership bought after the intro month covers 13 membership months in total, including one beyond the first twelve. Curex's price list doesn't say how many days each payment covers, so ask. These totals compare payment commitments, not equal periods of care.

If you want brand-name tirzepatide

At 7.5 mg and higher, Lilly's offer prices a Zepbound KwikPen at $449 for a 28-day supply. Outside the offer, it's $499 at 7.5 mg and $699 at 10 to 15 mg. To keep the $449 price, each refill purchase must be within 45 days of your last delivery, and the card expires December 31, 2026 (Lilly). The self-pay card requires an approved-use prescription, age 18 or older, U.S. or Puerto Rico residence, and no insurance reimbursement for those purchases. Pen needles cost extra.

That puts the $449 offer for brand-name Zepbound at $50 more per fill than Curex's $399 monthly base price for tirzepatide. It's closer than most people expect. But with 28-day supplies, the 11-fill limit, and separate prescriber costs, that $50 difference isn't a reliable yearly comparison.

If you already have a prescriber, Lilly's self-pay program skips any membership. If you want the prescriber and the program in one place, Ro lists the KwikPen at the same medicine prices plus its membership. Compare the two in Ro vs. LillyDirect, and see how the Zepbound savings card works.

If your clinician supports a compounded medicine

Then compare checkout terms side by side before you prepay anywhere. Every compounded program has fine print. The goal is to know yours.

Embody, another compounded program, advertises injection plans of 4, 12, 24, and 52 weeks. Its separate "Twelve Month Supply" product pages listed semaglutide at $828 and tirzepatide at $1,428 on October 20, 2026. Those are prepayments, equal to $69 or $119 a month, with no membership fee. Confirm which offer you're buying; 52 weeks and 12 calendar months are not exactly the same length. Embody says your price doesn't go up with your dose while you keep the same medication and plan. Its limits, in the same breath:

• Its Trustpilot rating was 3.8 from 10,296 reviews on October 20, 2026.
• Its refund policy (updated August 25, 2026) says payments, prepaid bundles included, are final. You must cancel at least 72 hours before the next bill. If a clinician finds you medically ineligible, you get the unused part back, minus services already provided.

Read our full Embody review for its terms.

If you've decided on a compounded shot, it's worth seeing Embody's checkout price and terms next to Curex's before you pay either one.

Paid link: See Embody's current pricing

Who Curex is for, and who should skip it

Curex may fit a cash-paying adult whose clinician supports a compounded medicine and who gets the price and refund terms in writing. It's a poor fit for anyone who wants an FDA-approved medicine, insurance billing, a refund they can rely on, or a needle-free option with trials behind it.

Try five quick yes-or-no checks:

1. Are you paying cash?
2. Has a clinician said a compounded medicine meets a need an FDA-approved one can't?
3. If you prepay, do you expect to reach the break-even point for your quote: 8 or 9 months at list prices, or 9 or 10 with the first-month sale? Or are you fine paying $299 to $399 a month?
4. Will you screenshot your checkout and get the guarantee terms in writing?
5. Has Curex confirmed that your medicine and form are available in your state? Its legal state list and sales pages disagree.

Five yeses? Curex may be worth a conversation once its written answers check out. Any no? The table points you somewhere better. "I don't know" is a fine answer too.

Curex doesn't offer any FDA-approved GLP-1. If FDA approval matters most, Ro is the better fit. Curex's listed plan charges are lower than the Ro cash-pay examples above.

If you have commercial insurance, check whether it covers an FDA-approved GLP-1 before you pay cash for a compounded one. Ro's free coverage check looks at Ozempic, Wegovy, and Zepbound autoinjector pens, and Ro says it handles the insurance paperwork. Some plans also need prior authorization, which is a permission slip from your insurer before it will pay. Ro's membership is a separate cost, and coverage isn't guaranteed.

Paid link: Check your coverage with Ro

Before you pay Curex: questions to send in writing

Send these before you check out, and save the reply. A written answer won't guarantee a refund, but it gives you a record if the charges don't match what you were told.

Write to hi@getcurex.com, or call or text (857) 240-1080. Suggested subject line: Confirm my Curex GLP-1 price and cancellation terms.

1. Which medicine, form, and dose would I get, and is it available in my state?
2. What is my exact price, and does it change when my dose goes up?
3. How much do I pay today, what does it cover (in days), and when and how much is the next charge?
4. Is this a monthly plan or prepaid? If prepaid, what happens to unused months if I stop?
5. If I'm not prescribed, do I get everything back, or do you keep a consultation fee? How much?
6. Where are the written terms of the 365-day money-back guarantee?
7. Which pharmacy will fill my order? Please send its name, address, and license details.
8. Are labs or extra medicines likely, and what would they cost?
9. What's my cancel deadline before each charge, and what happens if treatment changes or a product becomes unavailable?

If Curex can't answer one of these, that's not proof of anything wrong. It just means the offer isn't complete yet. Don't pay until it is.

Already a Curex customer? How to cancel or ask for a refund

To cancel or ask for a refund, email Curex or call or text (857) 240-1080. We didn't find step-by-step cancel instructions on the GLP-1 sales pages we checked. Its Terms say you can cancel before your next order starts being compounded, prepared, or shipped, and that prepaid months aren't refunded.

Asking a question about canceling isn't the same as canceling. Send a clear request:

Please cancel my Curex GLP-1 subscription and stop all future renewals. Please confirm in writing the effective date, any remaining scheduled charge, and the status of any pending shipment.

Then:

1. Use two channels. Email Curex and text or call with the same request. If your MyCurex account shows a cancel option, use it too. Note the date and time.
2. Get it in writing. Keep Curex's confirmation. If you don't get one, follow up.
3. Ask for a refund separately. Name the charge, the date, and the amount. Ask which policy applies and why.
4. For a medicine problem (warm on arrival, wrong label, a bad reaction), call the pharmacy on the label and report it to FDA's MedWatch program at 1-800-FDA-1088.
5. For side effects or dose questions, message your clinician. Billing staff can't change your treatment.

If you have a medical emergency, call 911.

What we actually verified

Last verified October 20, 2026. We read Curex's GLP-1 pages, sale page, landing pages, price list (prices as of October 12, 2026), Terms of Use (page dated November 1, 2021), state list, and FDA correspondence page. We checked Trustpilot and BBB, the FDA's warning letters to Curex, Boothwyn, and Empower, FDA's untitled letter to Vios, FDA's compounding pages and current shortage database, the Federal Register, the Wegovy, Zepbound, and Foundayo labels, FDA's Foundayo approval, Ro's pricing, Lilly's self-pay savings terms, and Embody's offer, 12-month product pages, terms, refund policy, and Trustpilot profile.

We did not buy anything, start a medical intake, see a checkout screen, or test Curex's customer service.

Our RX Index Score weighs six factors: clinical legitimacy and safety (25%), care and support model (20%), medication options and fit (15%), transparency and honest terms (15%), value / true cost (15%), and access and speed (10%). We haven't scored Curex, so this page uses our Decision Verdict instead. Read how we check providers.

Curex GLP-1 reviews: frequently asked questions

Is Curex legit?

Yes. Curex, Inc. is a real company, incorporated in 2019 and best known for online allergy care. Its GLP-1 program sells compounded drugs that aren't FDA-approved, the FDA sent it a warning letter about its GLP-1 ads in 2025, and the BBB rates it C. Read the terms closely.

Is there a Curex promo code?

On October 20, 2026, Curex's sale page showed a $49 first month for semaglutide and $149 for tirzepatide. We couldn't confirm a current code in the page text retrieved. Its separate price list shows $299 or $399 when paying monthly, but it doesn't tie those renewals to every sale. Check your exact first charge, plan length, and renewal amount.

Does Curex take insurance, HSA, or FSA?

Curex advertises its GLP-1 plans at self-pay prices. Curex says you can pay with an HSA or FSA card. Card acceptance isn't the same as the IRS rules for what counts, so see our HSA and FSA guide.

Which states does Curex serve?

Curex's own pages disagree. Its legal page lists 42 states, its main GLP-1 page leaves out seven, and its sale page says all 50, with only tablets in California. Confirm your state and your form before you pay.

Does Curex prescribe Ozempic, Wegovy, Zepbound, or Mounjaro?

No. Curex says it doesn't prescribe those brands; its GLP-1s are compounded semaglutide and tirzepatide. If you want an FDA-approved brand, you'll need a different path, such as your own doctor, LillyDirect, or Ro.

Has the FDA warned Curex?

Yes. The FDA sent Curex a warning letter on September 9, 2025, about claims for its compounded GLP-1s, such as "clinically proven success." According to letters Curex posted, the FDA followed up on May 27, 2026, and Curex says it made the requested changes by June 22, 2026.

How much does Curex cost per month after the sale?

Curex's price list says $299 a month for semaglutide or $399 for tirzepatide when you pay month to month. Prepaying a year costs $2,388 or $3,588 up front, which works out to $199 or $299 a month. At list prices, prepaying saves money at month 8 (semaglutide) or 9 (tirzepatide). If the $49/$149 first month applies and later charges match the list, those points move to months 9 and 10. Confirm the renewal price for your offer.

Does Curex's money-back guarantee work?

Curex advertises a 365-day money-back guarantee, but we couldn't find its full terms. The only condition we saw is a sale-page FAQ line: follow your treatment plan and don't lose weight. Curex's Terms say all fees are non-refundable, so get the guarantee's conditions in writing before you count on it.

Will I get a refund if I'm not prescribed?

Curex's ads say yes. Its Terms say a completed consultation is a non-refundable fee of up to $100, whether or not you're prescribed. Ask which applies to you before you pay.

Do Curex's tablets and drops work as well as shots?

We did not identify a published human trial showing that Curex's specific tablets or drops work as well as injections. No GLP-1 is FDA-approved as an under-the-tongue tablet or drops. Curex's own comments about lower potency are not clinical proof. FDA-approved swallowed pills, the Wegovy pill and Foundayo, are a separate option.

Which pharmacy fills Curex prescriptions?

Curex named four 503A pharmacies to the FDA in June 2026: Innovation Compounding Pharmacy, Boothwyn Pharmacy, RPC2B, and Vios Compounding Pharmacy. Your label names yours. Boothwyn received an FDA warning letter in January 2026 over weak and non-sterile GLP-1 lots.

How do I cancel Curex?

Email hi@getcurex.com or call or text (857) 240-1080, and ask in writing to cancel and stop all renewals. Do it before your next order starts being compounded or shipped, and keep the confirmation. Curex's Terms say prepaid months aren't refunded.

Sources

Sources checked October 20, 2026. The dates below label the original letters, policies, prices, and label revisions.

• Curex: GLP-1 page, sale page, landing pages (1, 2, 3, 4), price list (prices as of October 12, 2026), Terms of Use (page dated November 1, 2021), states where it operates, FDA correspondence (record current as of September 29, 2026)
• FDA: warning letter to Curex, September 9, 2025; warning letter to Boothwyn Pharmacy, January 16, 2026; untitled letter to Vios Compounding, September 18, 2023; warning letter to Empower Pharmacy, September 18, 2026; concerns with unapproved GLP-1 drugs (content current October 1, 2026); policies for compounders (content current April 1, 2026); current drug-shortage database; MedWatch
• FDA advertising context: September 9, 2025 crackdown on deceptive drug advertising
• Federal Register: 503B bulks list proposal, May 1, 2026; comment period extension, June 26, 2026
• Labels: Wegovy prescribing information (revised June 2026); Zepbound prescribing information (revised August 2026; rechecked October 20 after the October 19 source check); Foundayo FDA approval, April 1, 2026; Foundayo prescribing information (revised July 2026)
• Reviews: Trustpilot: Curex; BBB: Curex, Inc. profile, complaints, and customer reviews
• Other paths: Ro weight loss pricing, free insurance coverage checker; Lilly Zepbound savings, full self-pay terms; Embody: current offer, 12-month semaglutide product, 12-month tirzepatide product, Terms and Conditions, refund policy (updated August 25, 2026), Trustpilot
• Treatment persistence: Rodriguez et al., JAMA Network Open, January 31, 2025, a U.S. cohort of adults with overweight or obesity; not a study of Curex.